ALBERTDAVD

Albert David Share Price

₹817.00 -10.35 (-1.25%)

21 May, 2025 08:52

SIP TrendupStart SIP in ALBERTDAVD

Start SIP

Performance

  • Low
  • ₹813
  • High
  • ₹835
  • 52 Week Low
  • ₹763
  • 52 Week High
  • ₹1,754
  • Open Price₹821
  • Previous Close₹827
  • Volume3,769

Investment Returns

  • Over 1 Month -4.07%
  • Over 3 Month -9.71%
  • Over 6 Month -36.43%
  • Over 1 Year -30.99%
SIP Lightning

Smart Investing Starts Here Start SIP with Albert David for Steady Growth!

Invest Now

Albert David Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 27.1
  • PEG Ratio
  • -0.4
  • Market Cap Cr
  • 466
  • P/B Ratio
  • 1.1
  • Average True Range
  • 34.88
  • EPS
  • 30.12
  • Dividend Yield
  • 1.4
  • MACD Signal
  • -5.42
  • RSI
  • 45.25
  • MFI
  • 53.39

Albert David Financials

Albert David Technicals

EMA & SMA

Current Price
₹817.00
-10.35 (-1.25%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹835.87
  • 50 Day
  • ₹872.41
  • 100 Day
  • ₹969.93
  • 200 Day
  • ₹1,072.53

Resistance and Support

821.75 Pivot Speed
  • R3 851.85
  • R2 843.40
  • R1 830.20
  • S1 808.55
  • S2 800.10
  • S3 786.90

What's your outlook on Albert David?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Albert David Ltd manufactures and markets pharmaceutical formulations, intravenous fluids, and active pharmaceutical ingredients (APIs). Serving domestic and international markets, the company provides high-quality healthcare products across therapeutic segments like anti-infectives, gastroenterology, and nutraceuticals.

Albert David has an operating revenue of Rs. 345.77 Cr. on a trailing 12-month basis. An annual revenue de-growth of -11% needs improvement, Pre-tax margin of 7% is okay, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 30 which is a POOR score indicating inconsistency in earnings, a RS Rating of 14 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 76 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Albert David Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-13 Audited Results & Final Dividend
2025-02-12 Quarterly Results
2024-11-14 Quarterly Results
2024-08-09 Quarterly Results
2024-05-13 Audited Results & Final Dividend
Date Purpose Remarks
2024-08-02 FINAL Rs.11.50 per share(115%)Final Dividend
2023-08-03 FINAL Rs.9.00 per share(90%)Dividend
2022-08-02 FINAL Rs.9.00 per share(90%)Dividend
2021-09-07 FINAL Rs.6.00 per share(60%)Dividend
View More

Albert David F&O

Albert David Shareholding Pattern

62.24%
0.01%
1.61%
1%
0.01%
27.43%
7.7%

About Albert David

  • NSE Symbol
  • ALBERTDAVD
  • BSE Symbol
  • 524075
  • Managing Director & CEO
  • Mr. Umesh Manohar Kunte
  • ISIN
  • INE155C01010

Similar Stocks to Albert David

Albert David FAQs

Albert David share price is ₹817 As on 21 May, 2025 | 08:38

The Market Cap of Albert David is ₹466.3 Cr As on 21 May, 2025 | 08:38

The P/E ratio of Albert David is 27.1 As on 21 May, 2025 | 08:38

The PB ratio of Albert David is 1.1 As on 21 May, 2025 | 08:38

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23